Skip to content

Sex-Divergent Effects of Magnesium L-Threonate Supplementation on Sleep Quality, Cognitive Performance, and Neuromuscular Function in Healthy Adults

Sex-Divergent Effects of Magnesium L-Threonate Supplementation on Sleep Quality, Cognitive Performance Under Mental Fatigue, and Neuromuscular Function in Healthy Adults: A Randomized, Double-Blind, Placebo-Controlled Trial

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07706283
Enrollment
81
Registered
2026-07-15
Start date
2025-12-01
Completion date
2026-03-19
Last updated
2026-07-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Adults; Cognitive Performance; Sleep Quality; Neuromuscular Function

Keywords

magnesium L-threonate, mental fatigue, sleep quality, neuromuscular function, sex differences, countermovement jump, cognitive performance, ergogenic supplementation

Brief summary

This study examined the effects of six weeks of magnesium L-threonate (MgT) supplementation on sleep quality, cognitive performance under experimentally induced mental fatigue, neuromuscular function, and psychophysiological outcomes in healthy adults. Biological sex and weight status were examined as pre-specified moderating variables.

Detailed description

This study was a randomized, double-blind, placebo-controlled, parallel-group trial examining the effects of six weeks of magnesium L-threonate (MgT) supplementation on cognitive performance, mental fatigue, neuromuscular function, sleep quality, and psychophysiological outcomes in healthy adults. Biological sex and weight status were examined as pre-specified moderating variables given evidence for sex-specific differences in magnesium homeostasis and the elevated prevalence of magnesium inadequacy in individuals with overweight or obesity. Participants: Healthy male and female adults aged 18-45 years were recruited from a local university and surrounding community. Eighty-one participants were enrolled and randomized; the final analytic sample comprised 54 participants (MgT: n = 28; PLA: n = 26) following exclusions for non-adherence, technical data malfunction, and multivariate outlier removal. The sample was 59% female with a mean age of 23 ± 6 years and mean BMI of 26.7 ± 6.3 kg/m². Intervention: Participants assigned to the intervention group consumed 2 g·day-¹ of magnesium L-threonate (Magtein®; AIDP Inc., City of Industry, CA, USA) divided into two daily doses (morning and evening) for six weeks. Participants assigned to the placebo group consumed visually identical capsules containing rice powder (2 g·day-¹) on the same dosing schedule. Supplement compliance was assessed via capsule count at study conclusion; participants demonstrating less than 85% adherence were excluded from the final analytic sample. Testing Procedures: Participants completed identical testing sessions at baseline (Week 0) and following six weeks of supplementation (Week 6). All sessions were conducted at the same time of day for each participant to minimize circadian variability. Prior to each session, participants were instructed to abstain from caffeine for at least 12 hours, alcohol for 24 hours, and strenuous exercise for 24 hours. Testing was conducted in a standardized order as follows: Psychophysiological Questionnaires: Participants completed the Pittsburgh Sleep Quality Index (PSQI; 0-21 scale), Perceived Stress Scale (PSS), State-Trait Anxiety Inventory (STAI; state and trait subscales), and Visual Analog Scale for Fatigue (VAS-F; 0-100 mm) prior to any physical or cognitive testing. Neuromuscular Assessment - Pre-fatigue: Countermovement jump (CMJ) performance was assessed using dual force plates (VALD ForceDecks, VALD Performance, Brisbane, Australia). Variables of interest included jump height (cm), peak landing force (N), reactive strength index (m·s-¹), and concentric impulse (N·s). Cognitive Battery - Pre-fatigue: Cognitive performance was assessed using a computerized battery administered via the SOMA platform (SOMA Technologies, Lucerne, Switzerland). The battery included four tasks: the Psychomotor Fatigue Test (PFTT), Incongruent Flanker Task, Incongruent Stroop Task, and Task-Switching Test. Primary cognitive outcomes included reaction time (RT; ms), processing speed (1000/RT; s-¹), coefficient of variation (%), and rate correct score (correct responses·s-¹) derived from each task. Mental Fatigue Induction: Mental fatigue was induced via a standardized 20-minute time-load dual-back (TLDB) task. The VAS-F was administered immediately before and after the TLDB task to quantify changes in perceived fatigue. The NASA Task Load Index (NASA-TLX) was completed immediately following the TLDB task to assess subjective cognitive workload across six subscales: mental demand, physical demand, temporal demand, performance, effort, and frustration. Cognitive Battery - Post-fatigue: The full cognitive battery was repeated immediately following the TLDB protocol to assess performance under conditions of experimentally induced cognitive fatigue. Neuromuscular Assessment - Post-fatigue: CMJ testing was repeated following the post-fatigue cognitive battery to assess the effect of cognitive load on subsequent neuromuscular output. Statistical Analysis All analyses were performed in R with statistical significance set at α = 0.05. Primary outcomes were analyzed across three structurally distinct approaches: (1) absolute outcomes and within-bout change scores (pre- to post-mental fatigue) at W0 and W6 were analyzed using linear mixed models with fixed effects of condition, time, the condition-by-time interaction, and a random intercept for participant; (2) six-week change scores (W6 - W0) were analyzed using ANOVA with fixed effects of condition, sex, weight status, and the corresponding two- and three-way interactions; and (3) the change in the within-bout mental fatigue response across the six-week period was analyzed using analogous ANOVA to isolate whether MgT altered the magnitude of the acute mental fatigue response over time. Significant interaction effects were further assessed using post hoc comparisons with Bonferroni-Holm adjustment. Unadjusted simple effects tests were conducted when omnibus interactions were significant but adjusted post hoc comparisons were not, and are reported as exploratory. All primary models were re-estimated following removal of values exceeding ±3 SD to evaluate robustness of findings.

Interventions

DIETARY_SUPPLEMENTMagnesium L-threonate

Magnesium L-threonate

DIETARY_SUPPLEMENTPlacebo

Rice powder

Sponsors

Barry University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
DOUBLE (Subject, Investigator)

Masking description

Supplements were pre-labeled by batch number by an external party not involved in data collection. Capsules were visually identical in appearance. Group assignment was not disclosed to participants or study personnel until completion of all data collection and analysis.

Eligibility

Sex/Gender
ALL
Age
18 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy male or female adults aged 18-45 years * Free from diagnosed neurological, cardiovascular, metabolic, or psychiatric conditions * Not currently taking medications or supplements known to influence cognitive or neuromuscular function * Willing to maintain habitual diet, physical activity, and sleep routines throughout the study period

Exclusion criteria

* Pregnant or breastfeeding * Diagnosed sleep disorder * Initiated any new supplement or medication regimen within the past three months * Failed to meet ≥85% supplementation adherence threshold during the study (post-enrollment exclusion) * Technical data malfunction resulting in unrecoverable testing data (post-enrollment exclusion) * Identified as a multivariate outlier (values exceeding ±3 SD from the group mean on primary outcomes; post-enrollment exclusion)

Design outcomes

Primary

MeasureTime frameDescription
Pittsburgh Sleep Quality Index (PSQI)Baseline (Week 0) and post-intervention (Week 6)Subjective sleep quality assessed using the Pittsburgh Sleep Quality Index (PSQI; scored 0-21). Higher scores indicate poorer sleep quality. A score ≥5 indicates poor sleep quality.
Flanker Task Reaction TimeBaseline (Week 0) and post-intervention (Week 6), assessed before and after a 20-minute mental fatigue induction protocol at each visitReaction time (ms) on the Incongruent Flanker Task assessed via computerized cognitive battery (SOMA platform). Lower values indicate faster processing.
Countermovement Jump HeightBaseline (Week 0) and post-intervention (Week 6), assessed before and after a 20-minute mental fatigue induction protocol at each visitJump height (cm) assessed via dual force plates (VALD ForceDecks). Higher values indicate greater neuromuscular performance.

Secondary

MeasureTime frameDescription
Flanker Task Processing SpeedBaseline (Week 0) and post-intervention (Week 6), assessed before and after mental fatigue inductionProcessing speed (1000/RT; s-¹) on the Incongruent Flanker Task. Higher values indicate faster processing.
Flanker Task Rate Correct ScoreBaseline (Week 0) and post-intervention (Week 6), assessed before and after mental fatigue inductionRate correct score (correct responses·s-¹) on the Incongruent Flanker Task. Higher values indicate better integrated speed-accuracy performance.
Flanker Task Coefficient of VariationBaseline (Week 0) and post-intervention (Week 6), assessed before and after mental fatigue inductionIntraindividual response variability (%) on the Incongruent Flanker Task. Lower values indicate more consistent performance.
Stroop Task Reaction TimeBaseline (Week 0) and post-intervention (Week 6), assessed before and after mental fatigue inductionReaction time (ms) on the Incongruent Stroop Task assessed via computerized cognitive battery. Lower values indicate faster processing.
Stroop Task Processing SpeedBaseline (Week 0) and post-intervention (Week 6), assessed before and after mental fatigue inductionProcessing speed (1000/RT; s-¹) on the Incongruent Stroop Task. Higher values indicate faster processing.
Stroop Task Rate Correct ScoreBaseline (Week 0) and post-intervention (Week 6), assessed before and after mental fatigue inductionRate correct score (correct responses·s-¹) on the Incongruent Stroop Task. Higher values indicate better integrated speed-accuracy performance.
Psychomotor Fatigue Test Reaction TimeBaseline (Week 0) and post-intervention (Week 6), assessed before and after mental fatigue inductionReaction time (ms) on the Psychomotor Fatigue Test (PFTT). Lower values indicate faster psychomotor processing.
Psychomotor Fatigue Test Processing SpeedBaseline (Week 0) and post-intervention (Week 6), assessed before and after mental fatigue inductionProcessing speed (1000/RT; s-¹) on the PFTT. Higher values indicate faster psychomotor processing.
Psychomotor Fatigue Test Rate Correct ScoreBaseline (Week 0) and post-intervention (Week 6), assessed before and after mental fatigue inductionRate correct score (correct responses·s-¹) on the PFTT. Higher values indicate better integrated speed-accuracy performance.
Task-Switching Test Reaction TimeBaseline (Week 0) and post-intervention (Week 6), assessed before and after mental fatigue inductionReaction time (ms) on the Task-Switching Test (TSWT). Lower values indicate faster cognitive flexibility.
Task-Switching Test Processing SpeedBaseline (Week 0) and post-intervention (Week 6), assessed before and after mental fatigue inductionProcessing speed (1000/RT; s-¹) on the TSWT. Higher values indicate faster cognitive flexibility.
Task-Switching Test Rate Correct ScoreBaseline (Week 0) and post-intervention (Week 6), assessed before and after mental fatigue inductionRate correct score (correct responses·s-¹) on the TSWT. Higher values indicate better integrated speed-accuracy performance.
Time-Load Dual-Back Rate Correct ScoreBaseline (Week 0) and post-intervention (Week 6)Rate correct score (correct responses·s-¹) on the 20-minute time-load dual-back (TLDB) mental fatigue induction task.
Countermovement Jump Peak Landing ForceBaseline (Week 0) and post-intervention (Week 6), assessed before and after mental fatigue inductionPeak landing force (N) assessed via dual force plates (VALD ForceDecks).
Countermovement Jump Reactive Strength IndexBaseline (Week 0) and post-intervention (Week 6), assessed before and after mental fatigue inductionReactive strength index (m·s-¹) assessed via dual force plates (VALD ForceDecks). Higher values indicate greater neuromuscular efficiency.
Countermovement Jump Concentric ImpulseBaseline (Week 0) and post-intervention (Week 6), assessed before and after mental fatigue inductionConcentric impulse (N·s) assessed via dual force plates (VALD ForceDecks). Higher values indicate greater force application during the propulsive phase.
Pittsburgh Sleep Quality Index - Global Score ChangeChange from baseline (Week 0) to post-intervention (Week 6)Six-week change in PSQI global score stratified by sex and weight status.
Perceived Stress Scale (PSS)Baseline (Week 0) and post-intervention (Week 6)Perceived psychological stress assessed using the 10-item Perceived Stress Scale (scored 0-40). Higher scores indicate greater perceived stress.
State-Trait Anxiety Inventory - State Subscale (STAI-S)Baseline (Week 0) and post-intervention (Week 6)State anxiety assessed using the STAI state subscale (scored 20-80). Higher scores indicate greater anxiety.
State-Trait Anxiety Inventory - Trait Subscale (STAI-T)Baseline (Week 0) and post-intervention (Week 6)Trait anxiety assessed using the STAI trait subscale (scored 20-80). Higher scores indicate greater dispositional anxiety.
Visual Analog Scale for Fatigue (VAS-F)Baseline (Week 0) and post-intervention (Week 6), assessed before and after mental fatigue induction at each visitSubjective fatigue assessed using a 100 mm visual analog scale. Higher scores indicate greater perceived fatigue.
NASA Task Load Index (NASA-TLX)Baseline (Week 0) and post-intervention (Week 6), assessed immediately following mental fatigue inductionMultidimensional subjective workload assessed across six subscales: mental demand, physical demand, temporal demand, performance, effort, and frustration (each scored 0-20; total scored 0-120). Higher scores indicate greater perceived workload.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 16, 2026